Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [615]
News [1043]
Articles [54]
Editorials [2]
Conferences [96]
elearning [5]
Novel therapies add to oncologists’ treatment arsenal
Prof Noel Clarke, Prof Maria De Santis, Dr Heather Payne, Dr Kurt Miller
Novel therapies add to oncologists’ treatment arsenal ( Prof Noel Clarke, Prof Maria De Santis, Dr Heather Payne, Dr Kurt Miller )
27 Nov 2013
The role of molecular pathways in therapeutic response and outcomes in breast...
Dr Fabrice André - Institut Gustave Roussy, Villejuif, France
The role of molecular pathways in therapeutic response and outcomes in breast cancer ( Dr Fabrice André - Institut Gustave Roussy, Villejuif, France )
8 Nov 2013
Traditional and personalised models of therapy in gastrointestinal and...
Dr Jaume Capdevila - Vall d'Hebron University Hospita, Barcelona, Spain
Traditional and personalised models of therapy in gastrointestinal and endocrine tumours: the role of histological and clinical markers ( Dr Jaume Capdevila - Vall d'Hebron University Hospita, Barcelona, Spain )
8 Nov 2013
Future perspectives: realising the potential of personalised healthcare in...
Dr Jonathan Ledermann - University College London, United Kingdom
Future perspectives: realising the potential of personalised healthcare in gynaecological cancer ( Dr Jonathan Ledermann - University College London, United Kingdom )
8 Nov 2013
Role of metronomics in cancer clinical trials and practice in developing...
Prof Shripad Banavali - Tata Memorial Centre, Mumbai, India
Role of metronomics in cancer clinical trials and practice in developing countries ( Prof Shripad Banavali - Tata Memorial Centre, Mumbai, India )
19 Jul 2013
Latest on metastatic castration resistant prostate cancer from ASCO 2013
Professor Maria De Santis, Dr Kurt Miller, Dr Dana Rathkopf and Dr Charles Ryan
Latest on metastatic castration resistant prostate cancer from ASCO 2013 ( Professor Maria De Santis, Dr Kurt Miller, Dr Dana Rathkopf and Dr Charles Ryan )
7 Jun 2013
Integrating breast cancer genomics and proteomics
Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Integrating breast cancer genomics and proteomics ( Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA )
15 May 2013
Next wave of successful drug therapy strategies in HER2-positive breast cancer
Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium
Next wave of successful drug therapy strategies in HER2-positive breast cancer ( Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium )
15 May 2013
Genetic and clinical factors best for predicting late recurrence in oestrogen...
Dr Ivana Sestak - Queen Mary University of London, UK
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer ( Dr Ivana Sestak - Queen Mary University of London, UK )
15 May 2013
CD4 T cells in extensively inflitrated breast cancer signal organised immune...
Dr Karen Willard-Gallo - Université Libre de Bruxelles, Brussels, Belgium
CD4 T cells in extensively inflitrated breast cancer signal organised immune response and predict survival ( Dr Karen Willard-Gallo - Université Libre de Bruxelles, Brussels, Belgium )
15 May 2013
How do we design trials that improve outcome?
Dr Lisa Carey - University of North Carolina, Chapel Hill, USA
How do we design trials that improve outcome? ( Dr Lisa Carey - University of North Carolina, Chapel Hill, USA )
15 May 2013
The future of PI3K/AKT/mTOR inhibitors in breast cancer
Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA
The future of PI3K/AKT/mTOR inhibitors in breast cancer ( Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA )
15 May 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation